| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥8.83B | +54.3% |
| Gross profit | ¥8.83B | — |
| Operating income | ¥4.46B | — |
| Net income | ¥3.60B | +76.2% |
| Gross margin | 100.0% | Net margin 40.8% |
| Revenue Q/Q | +14.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | ¥4.27B | 48.4% |
| Tax & other | ¥0.86B | 9.8% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中信银行 ・ 中科曙光 ・ 药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物 ・ 豪威集团 ・ 华友钴业 ・ 瑞芯微 ・ 兆易创新
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies